tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Scorpion Stings D065008 1 associated lipids
Drug-Related Side Effects and Adverse Reactions D064420 3 associated lipids
Retrognathia D063173 1 associated lipids
End Stage Liver Disease D058625 1 associated lipids
Candidiasis, Invasive D058365 2 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Thrombotic Microangiopathies D057049 1 associated lipids
Central Serous Chorioretinopathy D056833 1 associated lipids
Leukoencephalopathies D056784 3 associated lipids
Netherton Syndrome D056770 1 associated lipids
Latent Tuberculosis D055985 1 associated lipids
Invasive Pulmonary Aspergillosis D055744 1 associated lipids
Keratosis, Actinic D055623 3 associated lipids
Multiple Pulmonary Nodules D055613 2 associated lipids
Pancreatitis, Graft D055589 1 associated lipids
Failed Back Surgery Syndrome D055111 3 associated lipids
Primary Graft Dysfunction D055031 1 associated lipids
Idiopathic Interstitial Pneumonias D054988 1 associated lipids
Dendritic Cell Sarcoma, Interdigitating D054739 1 associated lipids
Precursor Cell Lymphoblastic Leukemia-Lymphoma D054198 10 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Chen CH et al. Comparison of tuberculosis infection rates in a national database of renal transplant patients with data from a single center in Taiwan. 2014 Transplant. Proc. pmid:24656019
Hattori Y et al. Influence of cytochrome P450 3A5 polymorphisms on viral infection incidence in kidney transplant patients treated with tacrolimus. 2014 Transplant. Proc. pmid:24656015
Cusinato DA et al. Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients. 2014 Br J Clin Pharmacol pmid:24528196
McCormack PL Extended-release tacrolimus: a review of its use in de novo kidney transplantation. 2014 Drugs pmid:25352392
Ciancio G et al. Randomized trial of three induction antibodies in kidney transplantation: long-term results. 2014 Transplantation pmid:24477186
Okada K et al. [Single institution experience of HLA-haploidentical hematopoietic stem cell transplantation for children: current problems and perspective]. 2014 Rinsho Ketsueki pmid:24492043
Pedroso JA et al. Elderly kidney transplant recipient with intermittent fever: a case report of leishmaniasis with acute kidney injury during liposomal amphotericin B therapy. 2014 Transplant. Proc. pmid:25242789
Torres IB et al. The Interplay between inflammation and fibrosis in kidney transplantation. 2014 Biomed Res Int pmid:24991565
Wada A et al. Ribosome display and photo-cross-linking techniques for in vitro identification of target proteins of bioactive small molecules. 2014 Anal. Chem. pmid:24380432
Yargui L et al. Metabolic status of 1088 patients after renal transplantation: assessment of twelve years monitoring in Algiers Mustapha Hospital. 2014 Saudi J Kidney Dis Transpl pmid:24434409
Gounden V and Soldin SJ Tacrolimus measurement: building a better immunoassay. 2014 Clin. Chem. pmid:24415738
Takeuchi T et al. Post-marketing surveillance of the safety and effectiveness of tacrolimus in 3,267 Japanese patients with rheumatoid arthritis. 2014 Mod Rheumatol pmid:24261753
Czubkowski P et al. Cardiovascular risk factors after conversion from cyclosporine to tacrolimus in children after liver transplantation. 2014 Ann. Transplant. pmid:25409773
Guitard J et al. An unexpected diagnosis in a renal-transplant patient with proteinuria treated with everolimus: AL amyloidosis. 2014 Clin. Nephrol. pmid:24040781
Spagnoletti G et al. Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up. 2014 Transplant. Proc. pmid:25242756
Liu FL et al. FKBP12 regulates the localization and processing of amyloid precursor protein in human cell lines. 2014 J. Biosci. pmid:24499793
Favennec C et al. Consideration of the switch from twice-daily to once-daily tacrolimus in pediatric kidney transplant in daily clinical practice: pharmacokinetic parameters, patient satisfaction and medical practices. 2014 Pediatr Transplant pmid:25164065
Gupta AK et al. Efficient neutrophil extracellular trap induction requires mobilization of both intracellular and extracellular calcium pools and is modulated by cyclosporine A. 2014 PLoS ONE pmid:24819773
Schmid S et al. Volatility of serum creatinine relative to tacrolimus levels predicts kidney transplant rejection. 2014 Ann. Transplant. pmid:25123847
Guillén-Gómez E et al. Monocyte implication in renal allograft dysfunction. 2014 Clin. Exp. Immunol. pmid:24134783
Farkas K et al. Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis. 2014 Expert Rev Gastroenterol Hepatol pmid:24738535
Li T et al. Effect of FK506 nanospheres on regeneration of allogeneic nerve after transplant. 2014 Asian Pac J Trop Med pmid:25066398
Hamilton BK and Kalaycio M Maximizing the benefits of mycophenolate mofetil as graft-versus-host disease prophylaxis. 2014 Biol. Blood Marrow Transplant. pmid:25065905
Garriga-Companys S and Labrador-Horrillo M [Chronic spontaneous urticaria]. 2014 Med Clin (Barc) pmid:24120109
Kurzawski M et al. Impact of PPARA and POR polymorphisms on tacrolimus pharmacokinetics and new-onset diabetes in kidney transplant recipients. 2014 Pharmacogenet. Genomics pmid:24921414
Ji SM et al. Retrospective evaluation of the effect of mycophenolate mofetil dosage on survival of kidney grafts based on biopsy results. 2014 Transplant. Proc. pmid:25498056
Hosohata K et al. Association between CYP3A5 genotypes in graft liver and increase in tacrolimus biotransformation from steroid treatment in living-donor liver transplant patients. 2014 Drug Metab. Pharmacokinet. pmid:23955548
Foroncewicz B et al. Cyclosporine is superior to tacrolimus in liver transplant recipients with recurrent psoriasis. 2014 Ann. Transplant. pmid:25163829
Kern G et al. Tacrolimus increases Nox4 expression in human renal fibroblasts and induces fibrosis-related genes by aberrant TGF-beta receptor signalling. 2014 PLoS ONE pmid:24816588
Ishikawa Y and Bächinger HP A substrate preference for the rough endoplasmic reticulum resident protein FKBP22 during collagen biosynthesis. 2014 J. Biol. Chem. pmid:24821723
Földes G et al. Immunosuppressive agents modulate function, growth, and survival of cardiomyocytes and endothelial cells derived from human embryonic stem cells. 2014 Stem Cells Dev. pmid:24192059
Heilman RL et al. Delayed allograft inflammation following alemtuzumab induction for kidney transplantation. 2013 Sep-Oct Clin Transplant pmid:23924146
Benoit S and Hamm H Psoriasis from a prosthesis: unusual Koebner phenomenon in a girl with autoamputation of the leg. 2013 Sep-Oct Pediatr Dermatol pmid:23360396
Zahdi MR et al. Erosive pustular dermatosis of the scalp successfully treated with oral prednisone and topical tacrolimus. 2013 Sep-Oct An Bras Dermatol pmid:24173187
Riva N et al. [Pharmacovigilance of calcineurin inhibitor in peidatric kidney and liver transplantation]. 2013 Nov-Dec Farm Hosp pmid:24256007
Brodrick B et al. Influence of treatments on prognosis for vulvar lichen sclerosus: facts and controversies. 2013 Nov-Dec Clin. Dermatol. pmid:24160287
Bloom RD et al. A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients. 2013 Nov-Dec Clin Transplant pmid:24118450
Labirua-Iturburu A et al. Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease. 2013 May-Jun Clin. Exp. Rheumatol. pmid:23465087
Chen SY et al. Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism--a prospective, randomized, controlled study. 2013 May-Jun Clin Transplant pmid:23432535
Ramirez CB et al. Completely steroid-free immunosuppression in liver transplantation: a randomized study. 2013 May-Jun Clin Transplant pmid:23621629
Krishna N et al. Tacrolimus-induced paranoid delusions and fugue-like state. 2013 May-Jun Gen Hosp Psychiatry pmid:22959421
He L et al. Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids. 2013 May-Jun J. Nephrol. pmid:22956434
Kanzelmeyer NK et al. Correlations with six-month protocol biopsy findings in pediatric transplant recipients on low- and regular-dose CNI regimens. 2013 Mar-Apr Clin Transplant pmid:23414365
Tiwari R et al. Enhancements in healthcare information technology systems: customizing vendor-supplied clinical decision support for a high-risk patient population. 2013 Mar-Apr J Am Med Inform Assoc pmid:22813760
Albekairy A et al. Cytochrome P450 3A4FNx011B as pharmacogenomic predictor of tacrolimus pharmacokinetics and clinical outcome in the liver transplant recipients. 2013 Mar-Apr Saudi J Gastroenterol pmid:23481136
LaMattina JC et al. Native kidney function following liver transplantation using calcineurin inhibitors: single-center analysis with 20 years of follow-up. 2013 Mar-Apr Clin Transplant pmid:23294013
Alfson ED et al. Lysis of catatonic withdrawal by propofol in a bone-marrow transplant recipient with adenovirus limbic encephalitis. 2013 Mar-Apr Psychosomatics pmid:22705183
Yoshida EM et al. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection. 2013 Mar-Apr Ann Hepatol pmid:23396740
Castillo G et al. [Acute cellular rejection in a liver transplantation patient due to changing the brand of a generic immunosuppressant]. 2013 Jul-Sep Rev Gastroenterol Mex pmid:23866966
Bechstein WO et al. A comparative, randomized trial of concentration-controlled sirolimus combined with reduced-dose tacrolimus or standard-dose tacrolimus in renal allograft recipients. 2013 Jul-Aug Transplant. Proc. pmid:23953523
Zhao YJ et al. Late, severe, noninfectious diarrhea after renal transplantation: high-risk factors, therapy, and prognosis. 2013 Jul-Aug Transplant. Proc. pmid:23953533
Weiler N et al. Tacrolimus effects and side effects after liver transplantation: is there a difference between immediate and extended release? 2013 Jul-Aug Transplant. Proc. pmid:23953543
Stringa P et al. Ischemic preconditioning and tacrolimus pretreatment as strategies to attenuate intestinal ischemia-reperfusion injury in mice. 2013 Jul-Aug Transplant. Proc. pmid:23953566
Tachibana A et al. Repopulation of the immunosuppressed retrorsine-treated infant rat liver with human hepatocytes. 2013 Jul-Aug Xenotransplantation pmid:23683097
Favi E et al. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 2013 Jul-Aug Clin Transplant pmid:23710603
Eberlin M et al. Increased medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based immunosuppressive regimen. 2013 Jul-Aug Transplant. Proc. pmid:23726723
Satyanarayan HS et al. Efficacy and tolerability of combined treatment with NB-UVB and topical tacrolimus versus NB-UVB alone in patients with vitiligo vulgaris: a randomized intra-individual open comparative trial. 2013 Jul-Aug Indian J Dermatol Venereol Leprol pmid:23760325
Babalola O and Strober BE Treatment of atopic dermatitis in pregnancy. 2013 Jul-Aug Dermatol Ther pmid:23914886
Conti R et al. Jessner-Kanof disease: two effective and sure therapeutic options. 2013 Jul-Aug Dermatol Ther pmid:23914897
Chakkera HA et al. Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation. 2013 Jan-Feb Transplant. Proc. pmid:23375287
Tian Ch et al. B- and T-lymphocyte attenuator/herpes virus entry mediator as early indicators for acute rejection following kidney transplantation. 2013 Jan-Feb Transplant. Proc. pmid:23375291
Yao B et al. The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism. 2013 Jan-Feb Transplant. Proc. pmid:23375298
Miyazaki T et al. Two case reports of successful withdrawal of mycofenolate mofetil after living donor lobar lung transplantation. 2013 Jan-Feb Transplant. Proc. pmid:23375323
Chang HY et al. Long-term follow-up of arrhythmia characteristics and clinical outcomes in heart transplant patients. 2013 Jan-Feb Transplant. Proc. pmid:23375324
Al Nahdi N et al. First successful treatment of post-liver transplant hepatitis C fibrosing cholestatic hepatitis with boceprevir, peginterferon and ribavirin in a pre-transplant null responder. 2013 Jan-Feb Ann Hepatol pmid:23293209
Seco-Melantuche R et al. [Incidence of drug-induced thrombocytopenia in hospitalized patients]. 2013 Jan-Feb Farm Hosp pmid:23461497
Rao V et al. A non-induction renal sparing approach after liver transplantation: high dose mycophenolate mofetil with delayed, low-dose tacrolimus. 2013 Jan-Feb Transplant. Proc. pmid:23267806
Langone A et al. Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry. 2013 Jan-Feb Clin Transplant pmid:22861144
Shiba H et al. Switching from tacrolimus to cyclosporine A to prevent primary biliary cirrhosis recurrence after living-donor liver transplantation. 2013 Apr-Jun Int Surg pmid:23701152
Adamu B et al. New-onset diabetes after renal transplantation: a case series as seen in a Nigerian kidney transplant population. 2013 Apr-Jun Niger J Clin Pract pmid:23563475
Cangemi G et al. Comparison of antibody-conjugated magnetic immunoassay and liquid chromatography-tandem mass spectrometry for the measurement of cyclosporine and tacrolimus in whole blood. 2013 Apr-Jun Int J Immunopathol Pharmacol pmid:23755756
Tsapepas D et al. Sublingual tacrolimus: a pharmacokinetic evaluation pilot study. 2013 Pharmacotherapy pmid:23307542
Zhou YN et al. Effect of amlodipine on the pharmacokinetics of tacrolimus in rats. 2013 Xenobiotica pmid:23312000
Becker S et al. Evaluation of a novel commercial assay for the determination of cyclosporine A, tacrolimus, sirolimus, and everolimus by liquid chromatography-tandem mass spectrometric assay. 2013 Ther Drug Monit pmid:23188181
Narayanan M et al. Outcomes in African American kidney transplant patients receiving tacrolimus and mycophenolic acid immunosuppression. 2013 Transplantation pmid:23423268
Levitsky J et al. Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients. 2013 Hepatology pmid:22234876
White M et al. Cardiac signaling molecules and plasma biomarkers after cardiac transplantation: impact of tacrolimus versus cyclosporine. 2013 J. Heart Lung Transplant. pmid:24263023
Chen D et al. FK506 maturation involves a cytochrome p450 protein-catalyzed four-electron C-9 oxidation in parallel with a C-31 O-methylation. 2013 J. Bacteriol. pmid:23435975
Annesley TM et al. Standardization of LC-MS for therapeutic drug monitoring of tacrolimus. 2013 Clin. Chem. pmid:23902823
Yates CJ et al. Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin. 2013 Transplantation pmid:23902993
Carmona A et al. Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus-sirolimus on endothelial cells: protective effect of defibrotide. 2013 Biol. Blood Marrow Transplant. pmid:23845694
Mizuno S et al. Combination assays for evaluation of immune function and CYP3A5 genotype to identify the risk of infectious complications and mortality in living donor liver transplant patients. 2013 Ann. Transplant. pmid:23845965
Sun W et al. [Association factors analysis of diarrhea in patients receiving kidney transplantation]. 2013 Beijing Da Xue Xue Bao pmid:24136278
Maguire O et al. Nuclear translocation of nuclear factor of activated T cells (NFAT) as a quantitative pharmacodynamic parameter for tacrolimus. 2013 Cytometry A pmid:24136923
Thin LW et al. Oral tacrolimus for the treatment of refractory inflammatory bowel disease in the biologic era. 2013 Inflamm. Bowel Dis. pmid:23615528
Chapin RW et al. Case report: imaging features in a renal transplant patient with calcineurin inhibitor-induced pain syndrome (CIPS). 2013 Skeletal Radiol. pmid:23615775
Madeleine MM et al. HPV-related cancers after solid organ transplantation in the United States. 2013 Am. J. Transplant. pmid:24119294
Ogata H Response to Roblin and Del Tedesco. 2013 Inflamm. Bowel Dis. pmid:23538853
Ho ET et al. Once-daily extended-release versus twice-daily standard-release tacrolimus in kidney transplant recipients: a systematic review. 2013 Transplantation pmid:23542469
Martín-Cano FE et al. mTOR pathway and Ca²⁺ stores mobilization in aged smooth muscle cells. 2013 Aging (Albany NY) pmid:23661091
de Jonge H and Kuypers DR Response to "CYP3A5 genotype, but not CYP3A4*1b, CYP3A4*22, or hematocrit, predicts tacrolimus dose requirements in Brazilian renal transplant patients". 2013 Clin. Pharmacol. Ther. pmid:23665867
Viana RA et al. Negative functional interaction between cell integrity MAPK pathway and Rho1 GTPase in fission yeast. 2013 Genetics pmid:23934882
Fuchs U et al. Clinical outcome in cardiac transplant recipients receiving tacrolimus retard. 2013 Transplant. Proc. pmid:23769094
Gauthier AS et al. [Galenic and analytic development of tacrolimus 0.06% eye drops]. 2013 J Fr Ophtalmol pmid:23218600
Koc-Zorawska E et al. Vascular adhesion protein-1, a novel molecule, in kidney and heart allograft recipients. 2013 Transplant. Proc. pmid:23769096
Akhi SN et al. Uterine rejection after allogeneic uterus transplantation in the rat is effectively suppressed by tacrolimus. 2013 Fertil. Steril. pmid:23218920
Miyauchi T et al. Therapeutic targeting of the axonal and microvascular change associated with repetitive mild traumatic brain injury. 2013 J. Neurotrauma pmid:23796228
Nakane S et al. Successful treatment of stiff person syndrome with sequential use of tacrolimus. 2013 J. Neurol. Neurosurg. Psychiatr. pmid:23715915
Wojtusciszyn A et al. Continuous glucose monitoring after kidney transplantation in non-diabetic patients: early hyperglycaemia is frequent and may herald post-transplantation diabetes mellitus and graft failure. 2013 Diabetes Metab. pmid:23999231
Herzer K et al. [HCV reinfection after liver transplantation - management and first experiences with telaprevir-based triple therapy]. 2013 Dtsch. Med. Wochenschr. pmid:24002874